High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas
Authors
Keywords
Next-generation sequencing, Medullary thyroid carcinoma, Biomarkers, <em class=EmphasisTypeItalic >RET</em>, <em class=EmphasisTypeItalic >RAS</em>
Journal
VIRCHOWS ARCHIV
Volume 465, Issue 1, Pages 73-78
Publisher
Springer Nature
Online
2014-05-14
DOI
10.1007/s00428-014-1589-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer
- (2013) S. Barollo et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer
- (2013) David Viola et al. Future Oncology
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
- (2013) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer
- (2013) Robert I. Haddad JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
- (2013) Michele Simbolo et al. PLoS One
- Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel
- (2013) Aldo Scarpa et al. PLoS One
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vandetanib for the Treatment of Medullary Thyroid Cancer
- (2012) N. G. Chau et al. CLINICAL CANCER RESEARCH
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS
- (2012) Nishant Agrawal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
- (2012) Raffaele Ciampi et al. THYROID
- Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
- (2011) Caterina Mian et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High Prevalence ofRASMutations inRET-Negative Sporadic Medullary Thyroid Carcinomas
- (2011) Margarida M. Moura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality
- (2011) Alberto Zamò et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Sequencing technologies — the next generation
- (2009) Michael L. Metzker NATURE REVIEWS GENETICS
- Prognostic Significance of SomaticRETOncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
- (2007) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search